{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:51:39Z","timestamp":1791809499608,"version":"4.3.4"},"reference-count":48,"publisher":"American Chemical Society (ACS)","issue":"40","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["242102231057"],"award-info":[{"award-number":["242102231057"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["262102310415"],"award-info":[{"award-number":["262102310415"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The hypoxic tumor microenvironment of melanoma imposes a critical limitation on conventional type II photodynamic therapy (PDT), relying on oxygen for the generation of cytotoxic reactive oxygen species (ROS). To overcome this challenge, a donor-\u03c0-acceptor (D-\u03c0-A) bis-terpyridine ruthenium(II) complex, Ru(tpy)2TT, was rationally designed and synthesized to enable dual type I\/II ROS generation. The ROS production efficiency was quantitatively evaluated in B16 murine melanoma cells, and the antitumor efficacy was assessed in a syngeneic C57BL\/6N mouse melanoma model. Upon photoactivation at 500 nm, Ru(tpy)2TT efficiently generated both superoxide anion (type I ROS) and singlet oxygen (type II ROS). Intratumoral administration followed by localized irradiation resulted in an 80% reduction in tumor volume after 10 days, with no observed systemic toxicity or off-target effects. These findings demonstrate that Ru(tpy)2TT circumvents hypoxia-induced PDT resistance in melanoma via hypoxia-tolerant and oxygen-dependent ROS pathways, establishing its potential as a targeted precision antitumor agent. Furthermore, this work provides a generalizable molecular design strategy for developing hypoxia-tolerant PDT agents for refractory melanoma.<\/jats:p>","DOI":"10.1021\/acs.inorgchem.6c04054","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:01:17Z","timestamp":1790802077000},"page":"23983-23991","source":"Crossref","is-referenced-by-count":0,"title":["Rationally\nDesigned Ru(II) Complex with Dual Type\nI\/II ROS Generation for Hypoxia-Tolerant Photodynamic Therapy in Melanoma"],"prefix":"10.1021","volume":"65","author":[{"given":"Xueling","family":"Li","sequence":"first","affiliation":[{"name":"Henan University , , ,","place":["Kaifeng, P. R. China, 475004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Henan University , , ,","place":["Kaifeng, P. R. China, 475004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[{"name":"Henan University , , ,","place":["Kaifeng, P. R. China, 475004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5366-7413","authenticated-orcid":true,"given":"Weixia","family":"Qing","sequence":"additional","affiliation":[{"name":"Henan University , , ,","place":["Kaifeng, P. R. China, 475004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0082-9447","authenticated-orcid":true,"given":"Yong","family":"Wang","sequence":"additional","affiliation":[{"name":"Henan University , , ,","place":["Kaifeng, P. R. China, 475004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0587-8635","authenticated-orcid":true,"given":"Pengtao","family":"Ma","sequence":"additional","affiliation":[{"name":"Henan University , , ,","place":["Kaifeng, P. R. China, 475004"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"2026101208082513600_cit1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41568-023-00565-7","article-title":"The journey from melanocytes to melanoma","volume":"23","author":"Centeno","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"2026101208082513600_cit2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","article-title":"Cutaneous melanoma","volume":"402","author":"Long","year":"2023","journal-title":"Lancet"},{"key":"2026101208082513600_cit3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN\nestimates of incidence and mortality worldwide for 36 cancers in 185\ncountries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"2026101208082513600_cit4","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01734-x","article-title":"Immune checkpoint\ninhibitors for the treatment of solid\ntumors and lymphoma in the past 26 years (2000\u20132025)","volume":"18","author":"Huang","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"2026101208082513600_cit5","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02212-7","article-title":"Resistance\nmechanisms to immune checkpoint inhibitors:\nupdated insights","volume":"24","author":"Alsaafeen","year":"2025","journal-title":"Mol. Cancer"},{"key":"2026101208082513600_cit6","doi-asserted-by":"publisher","DOI":"10.3390\/cells14141057","article-title":"Influence\nof hypoxia on tumor heterogeneity, DNA repair,\nand cancer therapy: from molecular insights to therapeutic strategies","volume":"14","author":"Kunachowicz","year":"2025","journal-title":"Cells"},{"key":"2026101208082513600_cit7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118543","article-title":"Harnessing nanotechnology\nto modulate hypoxic tumor microenvironments: Enhanced strategies for\noncological innovations","volume":"191","author":"Ghassemifar","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"2026101208082513600_cit8","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment\nin cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduction Targeted Ther."},{"key":"2026101208082513600_cit9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4143\/crt.2025.200","article-title":"Understanding\nimmune cell adaptation\nto tumor hypoxia for maximized therapeutic efficacy of immunotherapy:\nBiology and non-invasive imaging application","volume":"58","author":"Oh","year":"2026","journal-title":"Cancer Res. Treat."},{"key":"2026101208082513600_cit10","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01684-4","article-title":"Unraveling the triad of hypoxia,\ncancer cell stemness, and drug resistance","volume":"18","author":"Shang","year":"2025","journal-title":"J.\nHematol. Oncol."},{"key":"2026101208082513600_cit11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3322\/caac.20114","article-title":"Photodynamic\ntherapy of cancer: an update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"2026101208082513600_cit12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1476228","article-title":"Applications and challenges\nof photodynamic therapy in the treatment of skin malignancies","volume":"15","author":"Hua","year":"2024","journal-title":"Front. Pharmacol."},{"key":"2026101208082513600_cit13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123900","article-title":"All-in-one molecular design of activatable phototheranostic platform\nfor potent hypoxia-tolerant photodynamic immunotherapy of cancer","volume":"328","author":"Chen","year":"2026","journal-title":"Biomaterials"},{"key":"2026101208082513600_cit14","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1039\/D5CC04610F","article-title":"Recent advances in\nnanophotosensitizers for overcoming\ntumor hypoxia in photodynamic therapy","volume":"62","author":"Li","year":"2026","journal-title":"Chem.\nCommun."},{"key":"2026101208082513600_cit15","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.apsb.2023.11.007","article-title":"Towards overcoming\nobstacles of type\nII photodynamic therapy: Endogenous production of light, photosensitizer,\nand oxygen","volume":"14","author":"Yu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"2026101208082513600_cit16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29862-9","article-title":"An unexpected strategy\nto alleviate hypoxia limitation of photodynamic\ntherapy by biotinylation of photosensitizers","volume":"13","author":"An","year":"2022","journal-title":"Nat. Commun."},{"key":"2026101208082513600_cit17","doi-asserted-by":"publisher","DOI":"10.1038\/s41427-021-00303-1","article-title":"Strategies\nto improve photodynamic therapy efficacy by relieving\nthe tumor hypoxia environment","volume":"13","author":"Shen","year":"2021","journal-title":"NPG Asia Mater."},{"key":"2026101208082513600_cit18","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1039\/D0SC00785D","article-title":"Type I photosensitizers based on\nphosphindole oxide for photodynamic therapy: apoptosis and autophagy\ninduced by endoplasmic reticulum stress","volume":"11","author":"Zhuang","year":"2020","journal-title":"Chem.\nSci."},{"key":"2026101208082513600_cit19","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202506412","article-title":"A hypoxia-triggered\nbioreduction of hydrophilic Type I photosensitizer\nfor switchable in vivo photoacoustic imaging and\nhigh-specificity cancer phototherapy","volume":"64","author":"Zhao","year":"2025","journal-title":"Angew.\nChem., Int. Ed."},{"key":"2026101208082513600_cit20","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202103978","article-title":"Conquering the hypoxia\nlimitation for photodynamic therapy","volume":"33","author":"Wan","year":"2021","journal-title":"Adv. Mater."},{"key":"2026101208082513600_cit21","doi-asserted-by":"publisher","DOI":"10.1002\/viw2.6","article-title":"Application of nanotechnology for enhancing photodynamic\ntherapy\nvia ameliorating, neglecting, or exploiting tumor hypoxia","volume":"1","author":"Hu","year":"2020","journal-title":"View"},{"key":"2026101208082513600_cit22","doi-asserted-by":"publisher","DOI":"10.3390\/bios12090722","article-title":"Type I photosensitizers\nbased on aggregation-induced emission: a\nrising star in photodynamic therapy","volume":"12","author":"Li","year":"2022","journal-title":"Biosensors"},{"key":"2026101208082513600_cit23","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202501911","article-title":"Recent progress\nof molecular design in organic type I photosensitizers","volume":"21","author":"Xiong","year":"2025","journal-title":"Small"},{"key":"2026101208082513600_cit24","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413365","article-title":"The current\nadvances\nin design strategy (indirect strategy and direct strategy) for Type-I\nphotosensitizers","volume":"12","author":"Ma","year":"2025","journal-title":"Adv. Sci."},{"key":"2026101208082513600_cit25","doi-asserted-by":"publisher","first-page":"4600","DOI":"10.1039\/D3TB00545C","article-title":"Recent advances in\ntype I organic photosensitizers for efficient photodynamic therapy\nfor overcoming tumor hypoxia","volume":"11","author":"Lu","year":"2023","journal-title":"J. Mater. Chem.\nB"},{"key":"2026101208082513600_cit26","doi-asserted-by":"publisher","first-page":"11192","DOI":"10.1039\/D0DT01684E","article-title":"Rational design\nof type I photosensitizers based on\nRu(ii) complexes for effective photodynamic therapy under hypoxia","volume":"49","author":"Liu","year":"2020","journal-title":"Dalton Trans."},{"key":"2026101208082513600_cit27","doi-asserted-by":"publisher","DOI":"10.1016\/j.dyepig.2024.111985","article-title":"Developing photo-activable\nruthenium (II) complexes for PDT: synthesis, characterization, photophysical\nand biological studies","volume":"224","author":"Parella","year":"2024","journal-title":"Dyes Pigm."},{"key":"2026101208082513600_cit28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16993-0","article-title":"Rationally\ndesigned ruthenium complexes\nfor 1- and 2-photon photodynamic therapy","volume":"11","author":"Karges","year":"2020","journal-title":"Nat.\nCommun."},{"key":"2026101208082513600_cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2022.214712","article-title":"Ru(II) containing photosensitizers\nfor photodynamic therapy: a critique\non reporting and an attempt to compare efficacy","volume":"470","author":"Munegowda","year":"2022","journal-title":"Coord. Chem. Rev."},{"key":"2026101208082513600_cit30","doi-asserted-by":"publisher","first-page":"18302","DOI":"10.1039\/D5CC05162B","article-title":"Insights into\ntype I photoreactivity\nof cyclometalated iridium(III) and ruthenium(II) photosensitizers","volume":"61","author":"Vigueras","year":"2025","journal-title":"Chem. Commun."},{"key":"2026101208082513600_cit31","doi-asserted-by":"publisher","first-page":"18510","DOI":"10.1021\/acs.inorgchem.3c02606","article-title":"Increasing the \u03c0-expansive\nligands in ruthenium(II) polypyridyl complexes: synthesis, characterization,\nand biological evaluation for photodynamic therapy applications","volume":"62","author":"Pozza","year":"2023","journal-title":"Inorg. Chem."},{"key":"2026101208082513600_cit32","doi-asserted-by":"publisher","first-page":"7360","DOI":"10.1021\/jacs.4c15036","article-title":"Ruthenium(II)\npolypyridyl complexes containing COUBPY ligands as potent photosensitizers\nfor the efficient phototherapy of hypoxic tumors","volume":"147","author":"Abad-Montero","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"2026101208082513600_cit33","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.14233\/ajchem.2023.28555","article-title":"A comprehensive\nreview for ruthenium(II) complexes in photodynamic therapy","volume":"35","author":"Mukherjee","year":"2023","journal-title":"Asian J. Chem."},{"key":"2026101208082513600_cit34","doi-asserted-by":"publisher","first-page":"8317","DOI":"10.1021\/jacs.2c02475","article-title":"Intraligand\nexcited states turn a ruthenium oligothiophene complex into a light-triggered\nubertoxin with anticancer effects in extreme hypoxia","volume":"144","author":"Roque","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"2026101208082513600_cit35","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202512296","article-title":"Cyclometalating ligand affords NIR absorption in ruthenium complexes\nfor Type-I photodynamic therapy","volume":"64","author":"Zhang","year":"2025","journal-title":"Angew. Chem.,\nInt. Ed."},{"key":"2026101208082513600_cit36","doi-asserted-by":"publisher","first-page":"27822","DOI":"10.1021\/jacs.5c06761","article-title":"Autonomous activation\nof a gated chemiluminescent photosensitizer enables targeted photodynamic\ntherapy in tumor cells","volume":"147","author":"Peng","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"2026101208082513600_cit37","doi-asserted-by":"publisher","first-page":"8648","DOI":"10.1021\/acs.jmedchem.5c00316","article-title":"Cascade responsive\nphotosensitizer for precise delivery and photodynamic therapy","volume":"68","author":"Zhang","year":"2025","journal-title":"J. Med. Chem."},{"key":"2026101208082513600_cit38","doi-asserted-by":"publisher","first-page":"17560","DOI":"10.1021\/ja207150n","article-title":"Tailor-made\ndual pH-sensitive\npolymer doxorubicin nanoparticles for efficient anticancer drug delivery","volume":"133","author":"Du","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"2026101208082513600_cit39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57533-y","article-title":"Aggregation induced emission luminogen bacteria hybrid bionic robot\nfor multimodal phototheranostics and immunotherapy","volume":"16","author":"Zhu","year":"2025","journal-title":"Nat. Commun."},{"key":"2026101208082513600_cit40","doi-asserted-by":"publisher","first-page":"13435","DOI":"10.1021\/acs.jmedchem.4c01307","article-title":"Donor-acceptor-donor\nstrategy rouses the photodynamic therapy anticancer activity of a\nbis-terpyridyl Ru(II) complex","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"key":"2026101208082513600_cit41","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202400049","article-title":"Combining\nmultiple photosensitizer modules into one supramolecular system for\nsynergetic enhanced photodynamic therapy","volume":"63","author":"Li","year":"2024","journal-title":"Angew.\nChem., Int. Ed."},{"key":"2026101208082513600_cit42","doi-asserted-by":"publisher","DOI":"10.1002\/anie.6178676","article-title":"A triple-acceptor motif for chalcogen-bond-directed circular assemblies\nthat enhance singlet oxygen generation","volume":"65","author":"Che","year":"2026","journal-title":"Angew.\nChem., Int. Ed."},{"key":"2026101208082513600_cit43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2025.113083","article-title":"Intercalative binding,\nlight-switch behavior, and theoretical analysis of Ru(bpy)2dppz-BTDZ]2+: A thiadiazole-extended ruthenium(II) complex","volume":"274","author":"Nogueira","year":"2026","journal-title":"J. Inorg. Biochem."},{"key":"2026101208082513600_cit44","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s10534-022-00404-6","article-title":"Interaction of organoruthenium(II)-polypyridyl\ncomplexes with DNA and BSA","volume":"35","author":"Margetic\u0301","year":"2022","journal-title":"BioMetals"},{"key":"2026101208082513600_cit45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2021.213888","article-title":"Photodynamic\ntherapy for hypoxic tumors: Advances and perspectives","volume":"438","author":"Huang","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"2026101208082513600_cit46","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28073028","article-title":"DNA binding and cleavage, stopped-flow\nkinetic, mechanistic,\nand molecular docking studies of cationic ruthenium(II) nitrosyl complexes\ncontaining \u201cNS4\u201d core","volume":"28","author":"Shereef","year":"2023","journal-title":"Molecules"},{"key":"2026101208082513600_cit47","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202504970","article-title":"A nucleus-targeting\nruthenium(II)\ncomplex induces DNA condensation in cisplatin-resistant tumor cells","volume":"64","author":"Zhou","year":"2025","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026101208082513600_cit48","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1021\/acs.organomet.5b00820","article-title":"Arene ruthenium(II)\ncomplexes as low-toxicity inhibitor against the\nproliferation, migration, and invasion of MDA-MB-231 cells through\nbinding and stabilizing c-myc G-quadruplex DNA","volume":"35","author":"Wu","year":"2016","journal-title":"Organometallics"}],"container-title":["Inorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.inorgchem.6c04054","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/inocaj\/article-pdf\/65\/40\/23983\/68720026\/acs.inorgchem.6c04054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/inocaj\/article-pdf\/65\/40\/23983\/68720026\/acs.inorgchem.6c04054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:43:07Z","timestamp":1791808987000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/inocaj\/article\/65\/40\/23983\/5443004\/Rationally-Designed-Ru-II-Complex-with-Dual-Type-I"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":48,"journal-issue":{"issue":"40","published-online":{"date-parts":[[2026,9,30]]},"published-print":{"date-parts":[[2026,10,12]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.inorgchem.6c04054","relation":{},"ISSN":["0020-1669","1520-510X"],"issn-type":[{"value":"0020-1669","type":"print"},{"value":"1520-510X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]}}}